Disease: Hepatitis D
- A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort
- A New Dawn in Hepatitis D Management
- A regular screening for hepatitis delta virus among chronic hepatitis B carriers improves the diagnostic of this infection and of subsequent cirrhosis development
- Addendum „Antivirale Therapie der chronischen Hepatitis-D-Virusinfektion“ zur S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS
- Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies
- Advances in hepatitis delta research: emerging insights and future directions
- An updated assessment of hepatitis delta prevalence among adults in Canada: A meta-analysis
- Analysis of Replication, Cell Division-Mediated Spread, and HBV Envelope Protein-Dependent Pseudotyping of Three Mammalian Delta-like Agents
- Antiviral Therapy of Chronic Hepatitis D Virus Infection - Addendum to the S3 Guideline "Prophylaxis, Diagnosis and Therapy of Hepatitis B Virus Infection" of the German Society for Gastroenterology, Digestive and Metabolic Diseases (DGVS)
- Assessment of performance and comparison of three commercial HDV RNA detection assays: implications for diagnosis and treatment monitoring
- Blocking viral entry with bulevirtide reduces the number of HDV-infected hepatocytes in human liver biopsies
- Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D
- Bulevirtide for the treatment of hepatitis B with hepatitis D virus coinfection
- Bulevirtide monotherapy in patients with chronic HDV: Efficacy and safety results through week 96 from a phase 3 randomized trial
- Cell Culture Models for Hepatitis B and D Viruses Infection: Old Challenges, New Developments and Future Strategies
- Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma
- Characterizing Hepatitis Delta in Spain and the gaps in its management
- Comparative analysis of human, rodent and snake deltavirus replication
- Current and future use of antibody-based passive immunity to prevent or control HBV/HDV infections
- Current perspectives of viral hepatitis
- Deciphering the Role of Post-Translational Modifications and Cellular Location of Hepatitis Delta Virus (HDV) Antigens in HDV-Mediated Liver Damage in Mice
- Delta hepatitis in Africa: epidemiological and clinical particularities
- Determinants of worse liver-related outcome according to HDV infection among HBsAg positive persons living with HIV: Data from the ICONA cohort
- Development of a dual channel detection system for pan-genotypic simultaneous quantification of hepatitis B and delta viruses
- Diagnosis and treatment of viral hepatitis B and D in 2024
- Dismantling Barriers to Hepatitis B and Delta Screening, Prevention, and Linkage to Care among the PWUD Community in Philadelphia
- Editorial: Liver elastography for chronic hepatitis D-the end of liver biopsy?
- Editorial: The current challenges underlying hepatitis D virus infection
- Efficacy of Newer Nucleos(t)ide Analogs After Hepatitis B Immunoglobulin Discontinuation Against Hepatitis B and D Recurrence in Liver Transplant Recipients
- Efficacy of Pegylated Interferon-alpha-2a in Chronic Hepatitis Delta: Experience from a Tertiary Care Hospital in Karachi
- Enrichment reveals extensive integration of hepatitis B virus DNA in hepatitis delta-infected patients
- Ergosterol peroxide blocks HDV infection as a novel entry inhibitor by targeting human NTCP receptor
- Estimating the prevalence of hepatitis delta virus infection among adults in the United States: A meta-analysis
- Evaluation of a fully automated high-throughput serology assay for detection of Hepatitis D virus antibodies
- Exosomes as Conduits: Facilitating Hepatitis B Virus-Independent Hepatitis D Virus Transmission and Propagation in Hepatocytes
- Growing Awareness: Limited Testing and Screening Bias for Hepatitis Delta Virus in Utah 2000-2021
- Hepatitis B Delta: assessment of the knowledge and practices of hepato-gastroenterologists practicing in non-academic settings in France
- Hepatitis B in Pediatric Population: Observational Retrospective Study in Romania
- Hepatitis B Vaccine: Four Decades on
- Hepatitis B Virus Infection: A Mini Review
- Hepatitis C Virus as a Possible Helper Virus in Human Hepatitis Delta Virus Infection
- Hepatitis D infection induces IFN-beta-mediated NK cell activation and TRAIL-dependent cytotoxicity
- Hepatitis D infection induces IFN-β-mediated NK cell activation and TRAIL-dependent cytotoxicity
- Hepatitis D virus reactivation in liver-transplanted patients receiving hepatitis B immunoglobulin
- Hepatitis delta testing trends in a US national cohort: An analysis of patient and provider-level predictive factors
- Hepatitis Delta Virus and Hepatocellular Carcinoma
- Hepatitis Delta Virus Reporting Requirements in the United States and Territories: A Systematic Review
- Hepatocyte Intrinsic Innate Antiviral Immunity against Hepatitis Delta Virus Infection: The Voices of Bona Fide Human Hepatocytes
- HepG2BD: A Novel and Versatile Cell Line with Inducible HDV Replication and Constitutive HBV Expression
- Highlights from the 2023 International Meeting on the Molecular Biology of Hepatitis B virus
- ICTV Virus Taxonomy Profile: <em>Kolmioviridae</em> 2024
- Immunological pathways in viral hepatitis-induced hepato-cellular carcinoma
- Impact of anti-HDV reflex testing at HBs antigen positive discovery in a single center France: Support for primary HDV screening in France
- Increase in HDV replication during steroid therapy - potential implications for testing and treatment strategies
- Independent predictors for non-alcoholic fatty liver disease in patients with treatment-naïve chronic hepatitis B
- Inhibition of cellular factor TM6SF2 suppresses secretion pathways of Hepatitis B, Hepatitis C and Hepatitis D viruses
- Inhibition of hepatic bile salt uptake by Bulevirtide reduces atherosclerosis in Oatp1a1<sup>-/-</sup>Ldlr<sup>-/-</sup> mice
- Investigating the Genetic Diversity of Hepatitis Delta Virus in Hepatocellular Carcinoma (HCC): Impact on Viral Evolution and Oncogenesis in HCC
- Is there a need for universal double reflex testing of HBsAg-positive individuals for hepatitis D infection?
- Leitlinienreport des Addendums „Antivirale Therapie der chronischen Hepatitis-D-Virusinfektion“ zur S3-Leitlinie „Prophylaxe, Diagnostik und Therapie der Hepatitis-B-Virusinfektion“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwe
- Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D
- Letter: Use of liver stiffness measurement to identify liver cirrhosis in patients with chronic hepatitis D-Authors' reply
- Liver stiffness measurement as a noninvasive method for the diagnosis of liver cirrhosis in patients with chronic hepatitis D virus infection
- Liver transplantation in viral and autoimmune liver diseases
- Long-term outcome of hepatitis delta in different regions world-wide: Results of the Hepatitis Delta International Network
- Long-Term Strategies for Poorly Water-Soluble Peptides: Combining Fatty Acid Modification with PAS Fusion
- Major open questions in the hepatitis B and D field - Proceedings of the inaugural International emerging hepatitis B and hepatitis D researchers workshop
- Management of chronic HBV-HDV patients chronic HBV-HDV infection: A review on new management options
- Method for Quantitative HDV RNA Detection: I, Manual Workflow (Serum and Liver Tissue) and II, Fully Automated High Throughput Workflow for Diagnostic Use
- Modelling HDV kinetics under the entry inhibitor bulevirtide suggests the existence of two HDV-infected cell populations
- Molecular determinants within the C-termini of L-HDAg that regulate hepatitis D virus replication and assembly
- Non-Invasive Prediction Scores for Hepatitis B Virus- and Hepatitis D Virus-Infected Patients-A Cohort from the North-Eastern Part of Romania
- Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction
- Persistence and risk factors of occult hepatitis B virus infections among antiretroviral therapy-naïve people living with HIV in Botswana
- Pharmacist-led patient education improves medication self-management and adherence in chronic hepatitis D virus patients: insights from the EXPLAIN project
- Point-of-Care Testing for Hepatitis Viruses: A Growing Need
- Prevalence and risk factors of transmission of hepatitis delta virus in pregnant women in the Center Region of Cameroon
- Prevalence of hepatitis B virus infection among general population of Armenia in 2021 and factors associated with it: a cross-sectional study
- Prevalence of hepatitis D virus infection among patients with chronic hepatitis B infection in a tertiary care centre in Thailand
- Prospective study of hepatitis B and D epidemiology and risk factors in Romania: A 10-year update
- Protective role of RIPK1 scaffolding against HDV-induced hepatocyte cell death and the significance of cytokines in mice
- Quantification of serum HDV RNA by Robogene 2.0 in HDV patients is significantly influenced by the extraction methods
- Recent treatment advances and practical management of hepatitis D virus
- Results of Response-Guided Therapy with Pegylated Interferon Alpha 2a in Chronic Hepatitis B and D
- Risk factors associated with hepatitis D virus infection and preventive strategies in Mongolia
- Safety and efficacy of off-label bulevirtide monotherapy in HDV patients with decompensated Child-B cirrhosis - a real world case series
- Salivary Glands and Viral Pathogenesis
- Seroprevalence and Risk Factors of Hepatitis B, C and D in Adults in Trabzon, Türkiye
- Seroprevalence of hepatitis D virus in Bulgarian outpatients with history of liver dysfunction
- Structure of antiviral drug bulevirtide bound to hepatitis B and D virus receptor protein NTCP
- The distinct spatiotemporal evolutionary landscape of HBV and HDV largely determines the unique epidemic features of HDV globally
- The Dynamics of the Prevalence of Acute Viral Hepatitis and the Strategies against Viral Hepatitis in Mongolia
- The Forgotten Virus, Hepatitis D: A Review of Epidemiology, Diagnosis, and Current Treatment Strategies
- Transporter Proteins as Therapeutic Drug Targets-With a Focus on SGLT2 Inhibitors
- Treatment of Hepatitis D - A Future Role for Combination Therapy
- Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort
- Understanding the Natural History of Chronic Hepatitis D: Proposal of a Model for Cost-Effectiveness Studies
- Unmet need in screening for hepatitis D virus: time to take action
- Validation of Baveno VII criteria and other non-invasive diagnostic algorithms for clinically significant portal hypertension in hepatitis delta
- What Is Hepatitis D Infection?